{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:53:37Z","timestamp":1761490417338},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T00:00:00Z","timestamp":1510012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T00:00:00Z","timestamp":1510012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The objective of this study was to investigate CXC chemokines and its receptor in patients with Behcet\u2019s disease (BD) and their associations with disease activity. Blood samples were collected from 109 BD patients and 36 age- and sex-matched healthy controls (HCs). Twenty-two follow-up blood samples were collected in BD patients. Serum CXC chemokines (CXCL1, CXCL8, CXCL9, CXCL10, CXCL12, CXCL13 and CXCL16) and cell surface marker expression (CD3, CD4 and CXCR3) in peripheral blood mononuclear cells (PBMCs) were assayed. Clinical features including disease activity were evaluated at the time of blood collection. CXCR3 expression in skin and intestinal lesions from BD patients and HCs was assessed via immunohistochemistry. Serum CXCL10 levels were correlated with disease activity in terms of Beh\u00e7et\u2019s Disease Current Activity Form (BDCAF) (p\u2009&lt;\u20090.001). In follow-up BD patients, changes in serum CXCL10 levels tended to be correlated with those of BDCAF. The percentage of CXCR3 expression in CD3-positive cells in PBMCs was inversely correlated with serum CXCL10 levels in BD patients (p\u2009=\u20090.022). By immunohistochemistry, the number of CXCR3-positive mononuclear cells was higher in skin and intestinal lesions of BD patients than in those of HCs. These results suggest that the CXCL10\/CXCR3 axis may contribute to the pathogenesis of BD.<\/jats:p>","DOI":"10.1038\/s41598-017-15189-9","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T12:17:21Z","timestamp":1509538641000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["CXCL10\/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Beh\u00e7et\u2019s disease"],"prefix":"10.1038","volume":"7","author":[{"given":"Sang Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin Eui","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Ha","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoong Yong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Masek-Hammerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jameel","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutian","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Neff-Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Bong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong Wook","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,7]]},"reference":[{"key":"15189_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane, T., Takeno, M., Suzuki, N. & Inaba, G. Behcet\u2019s disease. N Engl J Med. \n                           341, 1284\u20131291 (1999).","journal-title":"N Engl J Med."},{"key":"15189_CR2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.autrev.2011.12.005","volume":"11","author":"ZY Zhou","year":"2012","unstructured":"Zhou, Z. Y., Chen, S. L., Shen, N. & Lu, Y. Cytokines and Behcet\u2019s disease. Autoimmun Rev. \n                           11, 699\u2013704 (2012).","journal-title":"Autoimmun Rev."},{"key":"15189_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaut.2015.08.013","volume":"64","author":"M Takeuchi","year":"2015","unstructured":"Takeuchi, M., Kastner, D. L. & Remmers, E. F. The immunogenetics of Behcet\u2019s disease: A comprehensive review. J Autoimmun. \n                           64, 137\u2013148 (2015).","journal-title":"J Autoimmun."},{"key":"15189_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/BOR.0000000000000003","volume":"26","author":"A Gul","year":"2014","unstructured":"Gul, A. Genetics of Behcet\u2019s disease: lessons learned from genomewide association studies. Curr Opin Rheumatol. \n                           26, 56\u201363 (2014).","journal-title":"Curr Opin Rheumatol."},{"key":"15189_CR5","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1097\/MD.0000000000001858","volume":"94","author":"G Lopalco","year":"2015","unstructured":"Lopalco, G. et al. Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet\u2019s Disease. Medicine (Baltimore). \n                           94, e1858 (2015).","journal-title":"Medicine (Baltimore)."},{"key":"15189_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/icb.2015.15","volume":"93","author":"I Kufareva","year":"2015","unstructured":"Kufareva, I., Salanga, C. L. & Handel, T. M. Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies. Immunol Cell Biol. \n                           93, 372\u2013383 (2015).","journal-title":"Immunol Cell Biol."},{"key":"15189_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","volume":"36","author":"A Zlotnik","year":"2012","unstructured":"Zlotnik, A. & Yoshie, O. The chemokine superfamily revisited. Immunity. \n                           36, 705\u2013716 (2012).","journal-title":"Immunity."},{"key":"15189_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","volume":"13","author":"A Antonelli","year":"2014","unstructured":"Antonelli, A. et al. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. \n                           13, 272\u2013280 (2014).","journal-title":"Autoimmun Rev."},{"key":"15189_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.autrev.2012.10.001","volume":"12","author":"EY Lee","year":"2013","unstructured":"Lee, E. Y., Lee, Z. H. & Song, Y. W. The interaction between CXCL10 and cytokines in chronic inflammatory arthritis. Autoimmun Rev. \n                           12, 554\u2013557 (2013).","journal-title":"Autoimmun Rev."},{"key":"15189_CR10","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1093\/ndt\/gfp343","volume":"24","author":"L Schiffer","year":"2009","unstructured":"Schiffer, L. et al. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Nephrol Dial Transplant. \n                           24, 3708\u20133712 (2009).","journal-title":"Nephrol Dial Transplant."},{"key":"15189_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s13075-014-0434-z","volume":"16","author":"SR Greisen","year":"2014","unstructured":"Greisen, S. R. et al. CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic \u2018window of opportunity\u2019. Arthritis Res Ther. \n                           16, 434 (2014).","journal-title":"Arthritis Res Ther."},{"key":"15189_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13075-015-0773-4","volume":"17","author":"JH Han","year":"2015","unstructured":"Han, J. H. et al. Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still\u2019s disease. Arthritis Res Ther. \n                           17, 260 (2015).","journal-title":"Arthritis Res Ther."},{"key":"15189_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/BOR.0000000000000150","volume":"27","author":"DL Asquith","year":"2015","unstructured":"Asquith, D. L., Bryce, S. A. & Nibbs, R. J. Targeting cell migration in rheumatoid arthritis. Curr Opin Rheumatol. \n                           27, 204\u2013211 (2015).","journal-title":"Curr Opin Rheumatol."},{"key":"15189_CR14","first-page":"863","volume":"33","author":"H Hanaoka","year":"2015","unstructured":"Hanaoka, H. et al. Overexpression of CXCR4 on circulating B cells in patients with active systemic lupus erythematosus. Clin Exp Rheumatol. \n                           33, 863\u2013870 (2015).","journal-title":"Clin Exp Rheumatol."},{"key":"15189_CR15","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.imbio.2011.03.007","volume":"216","author":"AM El-Asrar","year":"2011","unstructured":"El-Asrar, A. M. et al. CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Immunobiology. \n                           216, 1004\u20131009 (2011).","journal-title":"Immunobiology."},{"key":"15189_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","volume":"145","author":"G Saruhan-Direskeneli","year":"2003","unstructured":"Saruhan-Direskeneli, G., Yentur, S. P., Akman-Demir, G., Isik, N. & Serdaroglu, P. Cytokines and chemokines in neuro-Behcet\u2019s disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol. \n                           145, 127\u2013134 (2003).","journal-title":"J Neuroimmunol."},{"key":"15189_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/cmi.2014.31","volume":"11","author":"K Hamzaoui","year":"2014","unstructured":"Hamzaoui, K., Borhani-Haghighi, A., Kaabachi, W. & Hamzaoui, A. Increased interleukin 33 in patients with neuro-Behcet\u2019s disease: correlation with MCP-1 and IP-10 chemokines. Cell Mol Immunol. \n                           11, 613\u2013616 (2014).","journal-title":"Cell Mol Immunol."},{"key":"15189_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fimmu.2012.00263","volume":"3","author":"A Stadtmann","year":"2012","unstructured":"Stadtmann, A. & Zarbock, A. CXCR2: From Bench to Bedside. Front Immunol. \n                           3, 263 (2012).","journal-title":"Front Immunol."},{"key":"15189_CR19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1084\/jem.187.6.875","volume":"187","author":"F Sallusto","year":"1998","unstructured":"Sallusto, F., Lenig, D., Mackay, C. R. & Lanzavecchia, A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. \n                           187, 875\u2013883 (1998).","journal-title":"J Exp Med."},{"key":"15189_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cytogfr.2014.11.009","volume":"26","author":"K Van Raemdonck","year":"2015","unstructured":"Van Raemdonck, K. et al. CXCR3 ligands in disease and therapy. Cytokine Growth Factor Rev. \n                           26, 311\u2013327 (2015).","journal-title":"Cytokine Growth Factor Rev."},{"key":"15189_CR21","first-page":"287","volume":"1836","author":"C Billottet","year":"2013","unstructured":"Billottet, C., Quemener, C. & Bikfalvi, A. CXCR3, a double-edged sword in tumor progression and angiogenesis. Biochim Biophys Acta. \n                           1836, 287\u2013295 (2013).","journal-title":"Biochim Biophys Acta."},{"key":"15189_CR22","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.4049\/jimmunol.177.9.6415","volume":"177","author":"M Melikoglu","year":"2006","unstructured":"Melikoglu, M. et al. Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers. J Immunol. \n                           177, 6415\u20136421 (2006).","journal-title":"J Immunol."},{"key":"15189_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.immuni.2012.08.016","volume":"37","author":"JR Groom","year":"2012","unstructured":"Groom, J. R. et al. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. Immunity. \n                           37, 1091\u20131103 (2012).","journal-title":"Immunity."},{"key":"15189_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaut.2005.09.027","volume":"26","author":"T Shigihara","year":"2006","unstructured":"Shigihara, T. et al. Significance of serum CXCL10\/IP-10 level in type 1 diabetes. J Autoimmun. \n                           26, 66\u201371 (2006).","journal-title":"J Autoimmun."},{"key":"15189_CR25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.immuni.2015.02.009","volume":"42","author":"HD Hickman","year":"2015","unstructured":"Hickman, H. D. et al. CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells. Immunity. \n                           42, 524\u2013537 (2015).","journal-title":"Immunity."},{"key":"15189_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/03009740600905380","volume":"35","author":"AM Dalghous","year":"2006","unstructured":"Dalghous, A. M., Freysdottir, J. & Fortune, F. Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet\u2019s disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD. Scand J Rheumatol. \n                           35, 472\u2013475 (2006).","journal-title":"Scand J Rheumatol."},{"key":"15189_CR27","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1002\/art.20334","volume":"50","author":"M Ben Ahmed","year":"2004","unstructured":"Ben Ahmed, M., Houman, H., Miled, M., Dellagi, K. & Louzir, H. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcet\u2019s disease. Arthritis Rheum. \n                           50, 2291\u20132295 (2004).","journal-title":"Arthritis Rheum."},{"key":"15189_CR28","doi-asserted-by":"crossref","unstructured":"Criteria for diagnosis of Behcet\u2019s disease. International Study Group for Behcet\u2019s Disease. Lancet. 335, 1078-1080 (1990).","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"15189_CR29","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3904\/kjim.2015.30.5.714","volume":"30","author":"HJ Choi","year":"2015","unstructured":"Choi, H. J., Seo, M. R., Ryu, H. J. & Baek, H. J. Cross-cultural adaptation and validation of the Behcet\u2019s Disease Current Activity Form in Korea. Korean J Intern Med. \n                           30, 714\u2013718 (2015).","journal-title":"Korean J Intern Med."},{"key":"15189_CR30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3904\/kjim.2016.31.1.170","volume":"31","author":"HJ Choi","year":"2016","unstructured":"Choi, H. J., Seo, M. R., Ryu, H. J. & Baek, H. J. Validation and reliability of a Behcet\u2019s Syndrome Activity Scale in Korea. Korean J Intern Med. \n                           31, 170\u2013175 (2016).","journal-title":"Korean J Intern Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15189-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15189-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15189-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:19:05Z","timestamp":1671801545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15189-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["15189"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-15189-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,7]]},"assertion":[{"value":"7 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14720"}}